 Colfax Corp NYSE: CFX reported third-quarter sales growth of 20 year-over-year to 965.89 million, 15 on an organic sales-per-day basis, beating the consensus of 958.430 million. Adjusted EPS improved to 0.54 from 0.41 in 3Q20, beating the consensus of 0.53. 